Showing results (41-50 of 198) with videos related to

Sort By:
Pageof 20
Neuropharmacology|April 13, 2007
Mechanisms of regulation for interleukin-1beta in neurodegenerative diseaseAnastasia Simi, Dominique Lerouet, Emmanuel Pinteaux, et al.
Disease Models & Mechanisms|February 14, 2012
Obese mice exhibit an altered behavioural and inflammatory response to lipopolysaccharideCatherine B Lawrence, David Brough, Elysse M Knight
The Journal of Biological Chemistry|September 2, 2015
Acid-dependent Interleukin-1 (IL-1) Cleavage Limits Available Pro-IL-1β for Caspase-1 CleavageMichelle E Edye, David Brough, Stuart M Allan
ANZ Journal of Surgery|March 26, 2024
Safety and feasibility of instituting a robotic pancreas program in the Australian setting: a case series and narrative reviewBartholomew McKay, David Brough, Daniel Kilburn, et al.
Iscience|February 8, 2024
Brazilin is a natural product inhibitor of the NLRP3 inflammasomeEmily McMahon, Sherihan El-Sayed, Jack Green, et al.
Journal of Alzheimer'S Disease : JAD|January 23, 2023
Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's DiseaseFelix Oluwasegun Ishabiyi, James Okwudirichukwu Ogidi, Baliqis Adejoke Olukade, et al.
Organic & Biomolecular Chemistry|May 16, 2008
Exciplex and excimer molecular probes: detection of conformational flip in a myo-inositol chairManikandan Kadirvel, Biljana Arsic, Sally Freeman, et al.
Brain Research|August 30, 2008
Neuronal injury induces the release of pro-interleukin-1beta from activated microglia in vitroPenglian Wang, Nancy J Rothwell, Emmanuel Pinteaux, et al.
European Journal of Medicinal Chemistry|February 18, 2011
Structure-activity relationship of 2,4,5-trioxoimidazolidines as inhibitors of thymidine phosphorylaseMehdi Rajabi, David Mansell, Sally Freeman, et al.
Pageof 20